Kevin Huang is a fellow at Nextech Invest Ltd, where he assists in deal sourcing and due diligence. Prior to Nextech, Kevin worked in life sciences consulting and startup business development. He has also conducted translational research on novel targeted therapy combinations in lung cancer and on colon cancer metabolism. Currently, he is an M.D. candidate at Harvard Medical School and hopes to use his medical training to develop transformative new medicines that will benefit cancer patients. Kevin holds a B.S. in molecular, cellular and development biology (intensive) from Yale University, where he graduated magna cum laude and Phi Beta Kappa.
In his free time, he enjoys playing the piano, cooking and doing trivia.